XML 87 R66.htm IDEA: XBRL DOCUMENT v3.20.4
Revenue (Details)
$ in Millions
12 Months Ended
Dec. 31, 2020
USD ($)
countries
Dec. 31, 2019
USD ($)
Dec. 31, 2018
USD ($)
Disaggregation of Revenue [Line Items]      
Emerging Markets total number of countries | countries 20    
Net sales $ 9,913 $ 10,735 $ 9,823
Contract with Customer, Liability [Abstract]      
Contract with Customer, Liability 395 400  
Change in Contract with Customer, Liability [Abstract]      
Contract with Customer, Liability, Cumulative Catch-up Adjustment to Revenue, Change in Estimate of Transaction Price 179    
Contract with Customer, Liability, Revenue Recognized 135    
UNITED STATES      
Disaggregation of Revenue [Line Items]      
Net sales 5,701 6,167 5,538
Non-US [Member]      
Disaggregation of Revenue [Line Items]      
Net sales 4,212 4,569 4,286
Emerging Markets [Member]      
Disaggregation of Revenue [Line Items]      
Net sales 1,093 1,252 1,097
Global Endoscopy (Endo) Reporting Unit [Member]      
Disaggregation of Revenue [Line Items]      
Net sales 1,780 1,894 1,762
Global Endoscopy (Endo) Reporting Unit [Member] | UNITED STATES      
Disaggregation of Revenue [Line Items]      
Net sales 1,000 1,080 980
Global Endoscopy (Endo) Reporting Unit [Member] | Non-US [Member]      
Disaggregation of Revenue [Line Items]      
Net sales 780 814 781
Global Urology and Pelvic Health Reporting Unit [Member]      
Disaggregation of Revenue [Line Items]      
Net sales 1,286 1,413 1,245
Global Urology and Pelvic Health Reporting Unit [Member] | UNITED STATES      
Disaggregation of Revenue [Line Items]      
Net sales 918 1,005 864
Global Urology and Pelvic Health Reporting Unit [Member] | Non-US [Member]      
Disaggregation of Revenue [Line Items]      
Net sales 368 408 381
Global CRM Reporting Unit [Member]      
Disaggregation of Revenue [Line Items]      
Net sales 1,704 1,939 1,951
Global CRM Reporting Unit [Member] | UNITED STATES      
Disaggregation of Revenue [Line Items]      
Net sales 992 1,135 1,159
Global CRM Reporting Unit [Member] | Non-US [Member]      
Disaggregation of Revenue [Line Items]      
Net sales 712 804 792
Global Electrophysiology (EP) Reporting Unit [Member]      
Disaggregation of Revenue [Line Items]      
Net sales 287 329 311
Global Electrophysiology (EP) Reporting Unit [Member] | UNITED STATES      
Disaggregation of Revenue [Line Items]      
Net sales 118 148 150
Global Electrophysiology (EP) Reporting Unit [Member] | Non-US [Member]      
Disaggregation of Revenue [Line Items]      
Net sales 169 180 161
Global Neuromodulation (NM) Reporting Unit [Member]      
Disaggregation of Revenue [Line Items]      
Net sales 761 873 779
Global Neuromodulation (NM) Reporting Unit [Member] | UNITED STATES      
Disaggregation of Revenue [Line Items]      
Net sales 610 695 624
Global Neuromodulation (NM) Reporting Unit [Member] | Non-US [Member]      
Disaggregation of Revenue [Line Items]      
Net sales 151 178 155
Global Interventional Cardiology (IC) Reporting Unit [Member]      
Disaggregation of Revenue [Line Items]      
Net sales 2,299 2,816 2,590
Global Interventional Cardiology (IC) Reporting Unit [Member] | UNITED STATES      
Disaggregation of Revenue [Line Items]      
Net sales 981 1,293 1,154
Global Interventional Cardiology (IC) Reporting Unit [Member] | Non-US [Member]      
Disaggregation of Revenue [Line Items]      
Net sales 1,317 1,522 1,436
Global Peripheral Interventions (PI) Reporting Unit [Member]      
Disaggregation of Revenue [Line Items]      
Net sales 1,577 1,392 1,187
Global Peripheral Interventions (PI) Reporting Unit [Member] | UNITED STATES      
Disaggregation of Revenue [Line Items]      
Net sales 888 741 608
Global Peripheral Interventions (PI) Reporting Unit [Member] | Non-US [Member]      
Disaggregation of Revenue [Line Items]      
Net sales 689 651 579
Specialty Pharmaceuticals [Member]      
Disaggregation of Revenue [Line Items]      
Net sales 219 81  
Specialty Pharmaceuticals [Member] | UNITED STATES      
Disaggregation of Revenue [Line Items]      
Net sales 193 70  
Specialty Pharmaceuticals [Member] | Non-US [Member]      
Disaggregation of Revenue [Line Items]      
Net sales 27 11  
BSX Reportable Segments      
Disaggregation of Revenue [Line Items]      
Net sales 9,694 10,654 9,823
BSX Reportable Segments | UNITED STATES      
Disaggregation of Revenue [Line Items]      
Net sales 5,508 6,097 5,538
BSX Reportable Segments | EMEA [Member]      
Disaggregation of Revenue [Line Items]      
Net sales 2,097 2,264 2,176
BSX Reportable Segments | APAC [Member]      
Disaggregation of Revenue [Line Items]      
Net sales 1,781 1,898 1,727
BSX Reportable Segments | Latin America and Canada [Member]      
Disaggregation of Revenue [Line Items]      
Net sales $ 307 $ 395 $ 383